{"filing":{"accession_number":"0001723464-26-000038","cik":"0001723464","ticker":"BHST","company_name":"BIOHARVEST SCIENCES INC.","form":"6-K","filing_date":"2026-07-15","report_date":null,"primary_document":"bhsc_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1723464/000172346426000038/bhsc_6k.htm"},"events":[{"id":18232,"run_id":16383,"accession_number":"0001723464-26-000038","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"BioHarvest announced receipt of a USD $1.4 million non-dilutive grant from the Israel Innovation Authority to fund a research initiative integrating AI, machine learning, and digital sensing into plant cell culture development. This is a material operational and strategic event—the grant funds a significant R\u0026D program that accelerates the company's technological transformation—but does not fit neatly into a specific category (not debt issuance, not equity dilution, not a discrete M\u0026A event). The non-dilutive nature and focus on R\u0026D advancement make `operational_other` the best fit, as it represents a material strategic partnership and funding milestone that would affect a reasonable investor's assessment of the company's R\u0026D capabilities and competitive position.","company_name":"BIOHARVEST SCIENCES INC.","ticker":"BHST","filing_date":"2026-07-15","form":"6-K","submitted_at":null,"items":[{"id":16982,"accession_number":"0001723464-26-000038","item_number":"EX-99.1","item_title":"bhsc_ex991.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"BioHarvest announced receipt of a USD $1.4 million non-dilutive grant from the Israel Innovation Authority to fund a research initiative integrating AI, machine learning, and digital sensing into plant cell culture development. This is a material operational and strategic event—the grant funds a significant R\u0026D program that accelerates the company's technological transformation—but does not fit neatly into a specific category (not debt issuance, not equity dilution, not a discrete M\u0026A event). The non-dilutive nature and focus on R\u0026D advancement make `operational_other` the best fit, as it represents a material strategic partnership and funding milestone that would affect a reasonable investor's assessment of the company's R\u0026D capabilities and competitive position.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-16T10:02:16.332353+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16982,"accession_number":"0001723464-26-000038","item_number":"EX-99.1","item_title":"bhsc_ex991.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"BioHarvest announced receipt of a USD $1.4 million non-dilutive grant from the Israel Innovation Authority to fund a research initiative integrating AI, machine learning, and digital sensing into plant cell culture development. This is a material operational and strategic event—the grant funds a significant R\u0026D program that accelerates the company's technological transformation—but does not fit neatly into a specific category (not debt issuance, not equity dilution, not a discrete M\u0026A event). The non-dilutive nature and focus on R\u0026D advancement make `operational_other` the best fit, as it represents a material strategic partnership and funding milestone that would affect a reasonable investor's assessment of the company's R\u0026D capabilities and competitive position.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-16T10:02:16.332353+00:00","company_name":"BIOHARVEST SCIENCES INC.","ticker":"BHST","filing_date":"2026-07-15"}]}